Danaparoid and anaemia Patient Reports February 12, 2012

Danaparoid Side Effects Report #4788262-2
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Sept 22, 2005. Male patient, 76 years of age, was diagnosed with thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, cardiac tamponade, coagulation test abnormal, pericardial haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with TICARCILLIN DI, CIPROFLOXACIN, OMEPRAZOLE, INSULIN, VITAMIN A, RIFAMPICIN. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5228777-6
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Jan 22, 2007. Male patient, 67 years of age, was diagnosed with thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, haematuria, thrombocytopenia. Danaparoid dosage: unknown. During the same period patient was treated with OFLOXACIN, OMEPRAZOLE, ENOXAPARIN. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5063665-X
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on July 18, 2006. Male patient, 75 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, gastrointestinal haemorrhage, melaena, purulent discharge, respiratory disorder. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5042436-4
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on June 14, 2006. Female patient, 50 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: abdominal haematoma, anaemia, leukopenia, neutropenia, platelet count decreased. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, OMEPRAZOLE, PAROXETINE HYDROCHLORIDE, FOLIC ACID, FERROUS SULPHATE. Patient was hospitalized. Patient recovered.


Danaparoid Side Effects Report #5061700-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 10, 2006. Female patient, 88 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood potassium decreased, blood urea increased, c-reactive protein increased, fibrin d dimer increased, platelet count decreased, prothrombin time prolonged. Danaparoid dosage: unknown. During the same period patient was treated with POLYGLOBIN, PRIMAXIN, DOPAMINE, FLOMOXEF. Patient recovered.

Danaparoid Side Effects Report #5022100-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 23, 2006. Female patient, 88 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood potassium decreased, blood urea increased, c-reactive protein increased, fibrin d dimer increased, prothrombin time prolonged, thrombocytopenia. Danaparoid dosage: unknown. During the same period patient was treated with POLYGLOBIN, PRIMAXIN, DOPAMINE, FLOMOXEF. Patient recovered.

Danaparoid Side Effects Report #5124738-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Female patient, 85 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, disseminated intravascular coagulation, lung disorder, pneumonia . Danaparoid dosage: unknown. During the same period patient was treated with AMPICILLIN, CLINDAMYCIN PHOSPHAGE, MINOCYCLINE HYDROCHLORIDE, ARBEKACIN SULPHATE, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, PHENYTOIN, SIVELESTAT. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5024706-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2006. Female patient, 85 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, disseminated intravascular coagulation, lung disorder, pneumonia . Danaparoid dosage: unknown. During the same period patient was treated with UNASYN, CLINDAMYCIN, MINOCYCLINE HYDROCHLORIDE, ARBEKACIN, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, PHENYTOIN, SILVELESTAT. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5030495-4
Danaparoid side effect was reported by a Health Professional from JAPAN on June 01, 2006. Female patient, 85 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, disseminated intravascular coagulation, lung disorder, pneumonia . Danaparoid dosage: unknown. During the same period patient was treated with AMPICILLIN, CLINDAMYCIN PHOSPHATE, MINOCYCLINE HYDROCHLORIDE, ARBEKACIN SULPHATE, ANTITHROMBIN III, IMMUNE GLOBULIN INTRAVENOUS, PHENYTOIN, SIVELESTAT. Patient was hospitalized. Patient died.


Danaparoid Side Effects Report #5116964-7
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Female patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, gastrointestinal haemorrhage, postoperative infection. Danaparoid dosage: unknown. During the same period patient was treated with CILASTATIN W, IMMUNE GLOBULIN INTRAVENOUS, ANTITHROMBIN III, CEFTAZIDIME, CLINDAMYCIN PHOSPHATE, MICAFUNGIN, ULINASTATIN, HYDROCORTISONE PHOSPHATE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5024707-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2006. Female patient, 82 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, postoperative infection. Danaparoid dosage: unknown. During the same period patient was treated with PRIMAXIN, IMMUNE GLOBULIN INTRAVENOUS, ANTITHROMBIN III, CEFTAZIDIME, CLINDAMYCIN, MICAFUNGIN, ULINASTATIN. Patient recovered.

Danaparoid Side Effects Report #4873367-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Dec 28, 2005. Female patient, 81 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, hypokalaemia, platelet count decreased, subdural haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE OPHTHALMIC, DOPAMINE, FUROSEMIDE, OMEPRAZOLE, GLYCERYL. Patient died.

Danaparoid Side Effects Report #4968091-7
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Mar 27, 2006. Female patient, 81 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, brain oedema, hypokalaemia, melaena, platelet count decreased, subdural haemorrhage, white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE OPHTHALMIC, DOPAMINE, LASIX, OMEPRAZOLE, GLYCEROL, CARBAZOCHROME SULFONATE. Patient died.

Danaparoid Side Effects Report #5020297-7
Danaparoid side effect was reported by a Consumer or non-health professional from ARMENIA on May 24, 2006. Female patient, 81 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, brain oedema, cerebral haemorrhage, gastrointestinal haemorrhage, hypokalaemia, melaena, platelet count decreased, prothrombin time prolonged, subdural haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE, DOPAMINE, LASIX, OMEPRAZOLE, GLYCEROL, CARBAZOCHROME SULFONATE. Patient died.


Danaparoid Side Effects Report #5020449-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 24, 2006. Female patient, 81 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, brain oedema, gastrointestinal haemorrhage, hypokalaemia, melaena, platelet count decreased, prothrombin time prolonged, subdural haemorrhage, white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PREDNISOLONE ACETATE, DOPAMINE, LASIX, OMEPRAZOLE, GLYCEROL, CARBAZOCHROME SULFONATE. Patient died.

Danaparoid Side Effects Report #4976157-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Mar 27, 2006. Male patient, 80 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood urea increased, condition aggravated, gastrointestinal haemorrhage, haemorrhagic diathesis, hyperkalaemia, jaundice , white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PLASMA PROTEIN FRACTION, SULPERAZON, PREDNISOLONE ACETATE OPHTHALMIC, AZASETRON HYDROCHLORIDE, PIRARUBICIN, VINCRISTINE SULPHATE, CYCLOPHOSPHAMIDE, CARBENIN. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #4976160-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Dec 28, 2005. Male patient, 80 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood urea increased, jaundice , white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PLASMA PROTEIN FRACTION, SULPERAZON, PREDNISOLONE ACETATE OPHTHALMIC, AZASETRON HYDROCHLORIDE, PIRARUBICIN, VINCRISTINE SULPHATE, CYCLOPHOSPHAMIDE, CARBENIN. Patient died.

Danaparoid Side Effects Report #5083999-2
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 07, 2006. Male patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, blood lactate dehydrogenase increased, blood potassium increased, blood urea increased, prothrombin time prolonged, subdural haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with MENATETRENONE, MAGNESIUM OXIDE, FAMOTIDINE, FUROSEMIDE, ALLOPURINOL. Patient died.

Danaparoid Side Effects Report #5029101-4
Danaparoid side effect was reported by a Health Professional from JAPAN on June 07, 2006. Male patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, blood lactate dehydrogenase increased, blood potassium increased, blood urea increased, platelet count decreased, prothrombin time prolonged, subdural haematoma. Danaparoid dosage: unknown. During the same period patient was treated with MENATETRENONE, MAGNESIUM OXIDE, FAMOTIDINE, FUROSEMIDE, ALLOPURINOL. Patient died.


Danaparoid Side Effects Report #4991406-0
Danaparoid side effect was reported by a Health Professional from AFGHANISTAN on Apr 25, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, disseminated intravascular coagulation, gastrointestinal haemorrhage, haemorrhage subcutaneous. Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM, CIMETIDINE, EPOETIN BETA, HEPARIN. Patient died.

Danaparoid Side Effects Report #4995842-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Apr 25, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disease progression, disseminated intravascular coagulation, gastrointestinal haemorrhage, haemorrhage subcutaneous, haemorrhagic diathesis, platelet count decreased. Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM, CIMETIDINE, EPOETIN BETA, HEPARIN. Patient died.

Danaparoid Side Effects Report #5033187-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 13, 2006. Male patient, 77 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, gastrointestinal haemorrhage, haemorrhage subcutaneous, platelet count decreased, prothrombin time prolonged. Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM, CIMETIDINE, EPOETIN BETA, HEPARIN. Patient died.

Danaparoid Side Effects Report #5113496-7
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Male patient, 75 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, hepatic function abnormal, shock haemorrhagic, wound infection. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, CEFAZOLIN, AMIKACIN SULPHATE, SACCHARATED IRON OXIDE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #4948454-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Mar 08, 2006. Male patient, 75 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, blood creatine increased, blood potassium increased, blood pressure decreased, gastrointestinal haemorrhage, haemoglobin decreased, haemoptysis, white blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, RIPAMPICIN, ISONIAZID, PYRIDOXAL PHOSPHATE. Patient died.


Danaparoid Side Effects Report #5027830-X
Danaparoid side effect was reported by a Health Professional from JAPAN on June 01, 2006. Male patient, 75 years of age, was diagnosed with disseminated intravascular coagulation, open fracture, iron deficiency anaemia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, hepatic function abnormal, wound infection. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, CEFAZOLIN, AMIKACIN SULPHATE, SACCARATED IRON OXIDE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5056237-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Apr 27, 2006. Male patient, 73 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, blood fibrinogen increased, blood lactate dehydrogenase increased, blood potassium decreased, fibrin degradation products increased, gamma-glutamyltransferase increased, leukopenia, malnutrition. Danaparoid dosage: unknown. During the same period patient was treated with CYTARABINE, GEMTUZUMAB OZOGAMICIN, ANTITHROMBIN III, CEFOZOPRAN HYDROCHLORIDE, MICAFUNGIN, TRANEXAMIC ACID, BIAPENEM, CLINDAMYCIN PHOSPHATE. Patient recovered.

Danaparoid Side Effects Report #5056239-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2006. Male patient, 73 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, blood fibrinogen increased, blood lactate dehydrogenase increased, blood potassium decreased, disease progression, fibrin degradation products increased, gamma-glutamyltransferase increased, leukopenia. Danaparoid dosage: unknown. During the same period patient was treated with CYTARABINE, GEMTUZUMAB OZOGAMICIN, ANTITHROMBIN III, CEFOZOPRAN HYDROCHLORIDE, MICAFUNGIN, TRANEXAMIC ACID, BIAPENEM, CLINDAMYCIN PHOSPHATE. Patient recovered.

Danaparoid Side Effects Report #5062425-3
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2006. Male patient, 73 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, blood fibrinogen increased, blood lactate dehydrogenase increased, blood potassium decreased, disease progression, fibrin degradation products increased, gamma-glutamyltransferase increased, haemorrhagic diathesis. Danaparoid dosage: unknown. During the same period patient was treated with CYTARABINE, GEMTUZUMAB OZOGAMICIN, ANTITHROMBIN III, CEFOZOPRAN HYDROCHLORIDE, MICAFUNGIN, TRANEXAMIC ACID, BIAPENEM, CLINDAMYCIN PHOSPHATE. Patient recovered.

Danaparoid Side Effects Report #4700514-0
Danaparoid side effect was reported by a Consumer or non-health professional from on June 21, 2005. Male patient, 71 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, gastritis haemorrhagic, hyperbilirubinaemia. Danaparoid dosage: unknown. During the same period patient was treated with NICORANDIL, BISPROLOL FUMARATE, NIFEDIPINE, ISOSORBIDE MONONITRATE, LANSOPRAZOLE, CARBOCISTEINE. Patient died.


Danaparoid Side Effects Report #4708673-0
Danaparoid side effect was reported by a Physician from JAPAN on June 28, 2005. Male patient, 71 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, gastritis haemorrhagic, hyperbilirubinaemia, pneumonia . Danaparoid dosage: unknown. During the same period patient was treated with NICORANDIL, BISOPROLOL FUMARATE, NIFEDIPINE, ISOSORBIDE MONONITRATE, LANSOPRAZOLE, CARBOCISTEINE. Patient died.

Danaparoid Side Effects Report #4968089-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Mar 27, 2006. Male patient, 64 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood urea increased, cerebral haemorrhage, convulsion, liver disorder, loss of consciousness. Danaparoid dosage: unknown. During the same period patient was treated with TRANEXAMIC ACID, CARBAZOCHROME SULFONATE, MENATETRENONE, CEFMETAZOLE, OMEPRAZOLE, PENTAZOCINE LACTATE, HYDROXYZINE HYDROCHLORIDE, DEXAMETHASONE. Patient died.

Danaparoid Side Effects Report #5019637-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on May 24, 2006. Male patient, 64 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood urea increased, cerebral haemorrhage, convulsion, liver disorder, loss of consciousness, prothrombin time prolonged. Danaparoid dosage: unknown. During the same period patient was treated with TRANEXAMIC ACID, CARBAZOCHROME SULFONATE, MENATETRENONE, CEFMETAZOLE, OMEPRAZOLE, PENTAZOCINE LACTATE, HYDROXYZINE HYDROCHLORIDE, DEXAMETHASONE. Patient died.

Danaparoid Side Effects Report #5084705-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 03, 2006. Male patient, 61 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, pulmonary alveolar haemorrhage, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, PIPERACILLIN, CLINDAMYCIN. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5097842-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 24, 2006. Male patient, 61 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, blood creatinine increased, pulmonary alveolar haemorrhage, renal impairment, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, PIPERACILLIN, CLINDAMYCIN. Patient was hospitalized. Patient recovered.


Danaparoid Side Effects Report #5030481-4
Danaparoid side effect was reported by a Health Professional from JAPAN on June 01, 2006. Female patient, 61 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, disease progression, disseminated intravascular coagulation. Danaparoid dosage: unknown. During the same period patient was treated with PENICILLIN G POTASSIUM. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5033184-5
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 12, 2006. Male patient, 61 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, condition aggravated, pulmonary alveolar haemorrhage, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, PIPERACILLIN, CLINDAMYCIN. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #5062431-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on July 07, 2006. Male patient, 58 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, aspartate aminotransferase increased, blood albumin decreased, blood fibrinogen increased, blood lactate dehydrogenase increased, blood potassium decreased, blood urea increased, fibrin d dimer increased. Danaparoid dosage: unknown. During the same period patient was treated with TRANEXAMIC ACID, DAUNOMYCIN, CYTARABINE, ANTITHROMBIN III, MINOPHAGEN C, CEFTAZIDIME. Patient recovered.

Danaparoid Side Effects Report #5113492-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Female patient was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anaemia, gastrointestinal haemorrhage, white blood cell count increased. Danaparoid dosage: unknown. During the same period patient was treated with CILASTATIN W, IMMUNE GLOBULIN INTRAVENOUS, ANTITHROMBIN III, CEFTAZIDIME, CLINDAMYCIN PHOSPHATE, MICAFUNGIN, ULINASTATIN, HYDROCORTISONE PHOSPHATE. Patient recovered.